Head-to-head · WeighScore
FeelGood vs ReadyRx
The verdict
FeelGood takes it — 69.5/100 to 67.8/100, but only just.
FeelGood grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth weight-loss program offering compounded GLP-1 medications (weekly injections and daily dissolvable tablets) plus limited brand-name options, prescribed by US-licensed providers and shipped to… ReadyRx is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | FeelGood | ReadyRx |
|---|---|---|
| WeighScore | 69.5/100 | 67.8/100 |
| Grade | C | C |
| Scorecard rank | #120 | #156 |
| Semaglutide | Not disclosed | $179/mo (starting dose, compounded) |
| Tirzepatide | Not disclosed | $255/mo (starting dose, compounded) |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #120 · C
Strengths
- Both compounded semaglutide (GLP-1) and tirzepatide (GLP-1 + GIP) formulations available
- Low compounded injection entry price ($149/mo) with no membership or hidden fees
- Oral/dissolvable tablet option for needle-averse patients
- LegitScript-certified site (seal #247923); OpenLoop Health telehealth backbone
- Free shipping and HSA/FSA eligibility
Where it loses points
- State availability not publicly disclosed on the site
- Compounding pharmacy partner not named publicly ("US-certified pharmacy" only)
- Brand-name ("Original") injections are expensive at $1,999/mo and limited in availability
Graded #156 · C
Strengths
- LegitScript Certified — verifiable via the badge link in the footer
- Batch lab testing covers the right QA metrics for injectables: potency, sterility, pH, and endotoxicity
- Pricing shown publicly: $179/mo semaglutide, $255/mo tirzepatide
Where it loses points
- Pharmacy partners not named — only described as 'FDA-registered compounding pharmacies'
- Clinicians described as licensed and board-certified, but no names or credentials published
- 5,000+ member figure comes from a directory listing, not an independent audit
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.